Co-pay support with RemiStart®
RemiStart® could help with your medication out-of-pocket costs
If you need help paying for your treatment with REMICADE®, you're not alone. Many people need help paying for their medication.
If your doctor thinks REMICADE® is the right choice for you, and you need assistance with your medication out-of-pocket costs, you may be eligible for the RemiStart® Patient Rebate Program.
If you have already participated in RemiStart®, you may be eligible for continuing support through the RemiStart® Extended Access Program.
RemiStart® Patient Rebate Program
Based on your eligibility, RemiStart® may provide a rebate for your medication out-of-pocket costs, including deductible, co-pay, and co-insurance, for up to 12 months,
8 infusions, or an $8,000 annual maximum benefit. RemiStart® rebates are determined by medication cost only. If eligible, you will pay just $50 per infusion (for up to 8 infusions). Rebate amounts are not determined by costs associated with administration of the IV infusion. Additional restrictions apply.*
You can find out more about eligibility requirements, restrictions, and program enrollment by visiting RemiStart.com .
$8,000 maximum benefit must be used within 12 months or for a maximum of 8 infusions within 12 months.
RemiStart® Extended Access Program
If you have already participated in RemiStart® and you have used up your 12 months in the program, you may qualify for continuing support from the RemiStart® Extended Access Program.
You can find out more about your eligibility for this program, restrictions, and the enrollment process by visiting RemiStart.com .
*For commercially insured patients only. Not valid for patients enrolled in Medicare or Medicaid.
REMICADE® can lower your ability to fight infections. Serious and sometimes fatal events can occur. There have been reports of serious infections including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body. Lymphoma, including a fatal kind called hepatosplenic T-cell lymphoma, and other cancers have been reported in children and adults taking REMICADE®. Some people with heart failure should not take REMICADE®. Other serious side effects reported include skin cancer, hepatitis B, liver injury, blood problems, allergic reactions, nervous system problems, or lupus-like syndrome. To learn more about these and other risks, please read the Important Safety Information and the Medication Guide , and talk with your doctor.